Cargando…
Inferring the true number of SARS-CoV-2 infections in Japan
INTRODUCTION: In Japan, as of December 31, 2021, more than 1.73 million laboratory-confirmed cases have been reported. However, the actual number of infections is likely to be under-ascertained due to the epidemiological characteristics such as mild and subclinical infections and limited testing ava...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359925/ https://www.ncbi.nlm.nih.gov/pubmed/35961504 http://dx.doi.org/10.1016/j.jiac.2022.08.002 |
_version_ | 1784764239032877056 |
---|---|
author | McKenzie, Lauren Shoukat, Affan Wong, Kai On Itahashi, Koju Yasuda, Eiji Demarsh, Alex Khan, Kamran |
author_facet | McKenzie, Lauren Shoukat, Affan Wong, Kai On Itahashi, Koju Yasuda, Eiji Demarsh, Alex Khan, Kamran |
author_sort | McKenzie, Lauren |
collection | PubMed |
description | INTRODUCTION: In Japan, as of December 31, 2021, more than 1.73 million laboratory-confirmed cases have been reported. However, the actual number of infections is likely to be under-ascertained due to the epidemiological characteristics such as mild and subclinical infections and limited testing availability in the early days of the pandemic. In this study, we infer the true number of infections in Japan between January 16, 2020, and December 31, 2021, using a statistical modelling framework that combines data on reported cases and fatalities. METHODS: We used reported COVID-19 deaths and age-specific infection fatality ratios (IFR) to impute the true number of infections. Estimates of IFR were informed from published studies and were adjusted to reflect the effects of pharmaceutical interventions, mass vaccination, and evolving variants. To account for the uncertainty in IFR, we sampled values from relevant distributions. RESULTS: We estimated that as of December 31, 2021, 3.07 million (CrI: 2.05–4.24 million) people had been infected in Japan, which is 1.77 times higher than the 1.73 million reported cases. Our meta-analysis confirmed that these findings were consistent with the intermittent seroprevalence studies conducted in Japan. CONCLUSIONS: We have estimated that a substantial number of COVID-19 infections in Japan were unreported, particularly in adults. Our approach provides a more realistic assessment of the true underlying burden of COVID-19. The results of this study can be used as fundamental components to strengthen population health control and surveillance measures. |
format | Online Article Text |
id | pubmed-9359925 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93599252022-08-09 Inferring the true number of SARS-CoV-2 infections in Japan McKenzie, Lauren Shoukat, Affan Wong, Kai On Itahashi, Koju Yasuda, Eiji Demarsh, Alex Khan, Kamran J Infect Chemother Original Article INTRODUCTION: In Japan, as of December 31, 2021, more than 1.73 million laboratory-confirmed cases have been reported. However, the actual number of infections is likely to be under-ascertained due to the epidemiological characteristics such as mild and subclinical infections and limited testing availability in the early days of the pandemic. In this study, we infer the true number of infections in Japan between January 16, 2020, and December 31, 2021, using a statistical modelling framework that combines data on reported cases and fatalities. METHODS: We used reported COVID-19 deaths and age-specific infection fatality ratios (IFR) to impute the true number of infections. Estimates of IFR were informed from published studies and were adjusted to reflect the effects of pharmaceutical interventions, mass vaccination, and evolving variants. To account for the uncertainty in IFR, we sampled values from relevant distributions. RESULTS: We estimated that as of December 31, 2021, 3.07 million (CrI: 2.05–4.24 million) people had been infected in Japan, which is 1.77 times higher than the 1.73 million reported cases. Our meta-analysis confirmed that these findings were consistent with the intermittent seroprevalence studies conducted in Japan. CONCLUSIONS: We have estimated that a substantial number of COVID-19 infections in Japan were unreported, particularly in adults. Our approach provides a more realistic assessment of the true underlying burden of COVID-19. The results of this study can be used as fundamental components to strengthen population health control and surveillance measures. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022-11 2022-08-09 /pmc/articles/PMC9359925/ /pubmed/35961504 http://dx.doi.org/10.1016/j.jiac.2022.08.002 Text en © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article McKenzie, Lauren Shoukat, Affan Wong, Kai On Itahashi, Koju Yasuda, Eiji Demarsh, Alex Khan, Kamran Inferring the true number of SARS-CoV-2 infections in Japan |
title | Inferring the true number of SARS-CoV-2 infections in Japan |
title_full | Inferring the true number of SARS-CoV-2 infections in Japan |
title_fullStr | Inferring the true number of SARS-CoV-2 infections in Japan |
title_full_unstemmed | Inferring the true number of SARS-CoV-2 infections in Japan |
title_short | Inferring the true number of SARS-CoV-2 infections in Japan |
title_sort | inferring the true number of sars-cov-2 infections in japan |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359925/ https://www.ncbi.nlm.nih.gov/pubmed/35961504 http://dx.doi.org/10.1016/j.jiac.2022.08.002 |
work_keys_str_mv | AT mckenzielauren inferringthetruenumberofsarscov2infectionsinjapan AT shoukataffan inferringthetruenumberofsarscov2infectionsinjapan AT wongkaion inferringthetruenumberofsarscov2infectionsinjapan AT itahashikoju inferringthetruenumberofsarscov2infectionsinjapan AT yasudaeiji inferringthetruenumberofsarscov2infectionsinjapan AT demarshalex inferringthetruenumberofsarscov2infectionsinjapan AT khankamran inferringthetruenumberofsarscov2infectionsinjapan |